Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent

Stock Information for Medipharm Labs Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Medipharm Labs Corp

MediPharm Labs Provides Conference Call Recording Details
MediPharm Labs Reports Fourth Quarter and Full Year Results
MediPharm Labs Provides Update on German Cannabis Legalization
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
MediPharm Labs Reports Third Quarter Results
MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.